Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 19 | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Leishmania major | cytochrome p450-like protein | cytochrome P450, family 2, subfamily C, polypeptide 19 | 490 aa | 411 aa | 23.1 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 490 aa | 441 aa | 21.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3889 | 0.7586 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.014 | 0.9286 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.2311 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.2311 | 0.4508 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1923 | 0.1885 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.0545 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.7888 | 0.7878 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.1923 | 0.3751 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.1923 | 0.3751 |
Brugia malayi | TAR-binding protein | 0.0065 | 0.3889 | 0.3537 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.1923 | 0.3751 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0545 | 0.1402 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0019 | 0.0545 | 0.1402 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.2311 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0217 | 0.0171 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0038 | 0.1923 | 0.1458 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.012 | 0.7888 | 0.7878 |
Brugia malayi | hypothetical protein | 0.0043 | 0.2311 | 0.1868 |
Echinococcus multilocularis | tar DNA binding protein | 0.0065 | 0.3889 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0065 | 0.3889 | 0.386 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.2311 | 0.5 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0545 | 0.5 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.0545 | 0.5 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0038 | 0.1923 | 0.4945 |
Schistosoma mansoni | hypothetical protein | 0.0082 | 0.5127 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.2311 | 0.5942 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0019 | 0.0545 | 0.5 |
Echinococcus granulosus | roundabout 2 | 0.0015 | 0.0217 | 0.0559 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0065 | 0.3889 | 0.3537 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3889 | 0.7586 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.2311 | 0.5942 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.012 | 0.7888 | 0.7766 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0055 | 0.3122 | 0.3089 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0545 | 0.1402 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0545 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.5127 | 0.5104 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0038 | 0.1923 | 0.4945 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0019 | 0.0545 | 0.1064 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3889 | 0.7586 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0038 | 0.1923 | 0.4945 |
Echinococcus granulosus | GPCR family 2 | 0.0038 | 0.1923 | 0.4945 |
Loa Loa (eye worm) | TAR-binding protein | 0.0065 | 0.3889 | 0.386 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0019 | 0.0545 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0055 | 0.3122 | 0.2725 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.2311 | 0.4508 |
Brugia malayi | RNA binding protein | 0.0065 | 0.3889 | 0.3537 |
Echinococcus multilocularis | roundabout 2 | 0.0015 | 0.0217 | 0.0559 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0038 | 0.1923 | 0.4945 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0082 | 0.5127 | 0.4846 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0545 | 0.1402 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3889 | 0.7586 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.012 | 0.7888 | 0.7766 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0019 | 0.0545 | 0.1402 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0019 | 0.0545 | 0.5 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.015 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0065 | 0.3889 | 0.386 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0038 | 0.1923 | 0.1885 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0019 | 0.0545 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0065 | 0.3889 | 1 |
Schistosoma mansoni | cell adhesion molecule | 0.0012 | 0.0047 | 0.0092 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0019 | 0.0545 | 0.5 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0019 | 0.0545 | 0.0501 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0217 | 0.0171 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3889 | 0.7586 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.2311 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0038 | 0.1923 | 0.4945 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0012 | 0.0047 | 0.0121 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0545 | 0.1402 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0545 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0038 | 0.1923 | 0.1458 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.1923 | 0.3751 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | = 7.943282347 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 14.12537545 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 22.38721139 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485342, AID485388] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398] | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.